Cresset® Creates New Vice President Role to Lead their Artificial Intelligence (AI) Strategy
Cambridge, 15th April 2024 – Cresset an innovative provider of solutions for CADD, DMTA efficiency, and contract research, has expanded ...
News
Cambridge, UK – 30th June 2014 – Cresset, innovative provider of computational chemistry software and services, announces the release of Torch V10.3. This version includes significant new science enabling medicinal chemists to visualize and optimize multiple activities to make the best molecular design decisions.
“An important part of modern medicinal chemistry is to understand how improving one property is likely to affect other properties,” says Dr Tim Cheeseright, Director of Products at Cresset. “This new release of Torch enables chemists to analyse and visualize their project data in an intuitive way while balancing multiple activity goals.”
Highlights of this release:
Dr Robert Scoffin, Cresset’s CEO, says, “We spend a lot of time listening to our customers, and many of these new features have been developed in response to specific customer input and feedback. We are confident that Torch V10.3 will significantly improve the ability of medicinal chemists to make the best use of their project data to make informed design decisions.”